
Drug trade margin cap flagged to PM
The Hindu
Expressing concern over the huge difference of margin and sale price between the retailer and MRP on life-saving drugs like Remdesivir, founder President of the Nizamabad Chamber of Commerce and Indus
Expressing concern over the huge difference of margin and sale price between the retailer and MRP on life-saving drugs like Remdesivir, founder President of the Nizamabad Chamber of Commerce and Industry P.R.Somani has urged the intervention of Prime Minister Narendra Modi. In a letter, Mr. Somani urged the Centre to fix a ceiling on trade margin cap on life-saving drugs. He was referring to severe shortage of Remdesivir and how hospitals and pharmacies were exploiting needy patients. He pointed out that all manufacturers are selling Remdesivir injection to retailers between ₹595 and ₹1,000 but the MRP printed is up to ₹5,400 and hospitals/pharmacies are selling at that high a rate. He lamented that in this pandemic situation when the entire country was struggling, people were being made to pay exorbitant prices for medicines.
‘Instead of accusing Gen-Z of lacking skills or discipline, we need to ask what drives them’ Premium
At a recent event held in the city, Cambridge University Press & Assessment launched an advisory panel comprising leaders from top global corporations, aiming to bridge the employability gap in India and better align academic output with industry needs. A whitepaper released at the event highlighted the growing importance of communication skills, the need for stronger collaboration between industry and universities, and strategies to bridge the persistent skill gap.

Under the NBS, newborns are screened for communication disorders before they are discharged from the hospital. For this, AIISH has collaborated with several hospitals to conduct screening which is performed to detect hearing impairment and other developmental disabilities that can affect speech and language development. The screening has been helping in early intervention for those identified with the disorders, as any delay in the identification poses risk and affects successful management of children with hearing loss, according to AIISH.